Detalhe da pesquisa
1.
Antiviral activity of danoprevir (ITMN-191/RG7227) in combination with pegylated interferon α-2a and ribavirin in patients with hepatitis C.
J Infect Dis
; 204(4): 601-8, 2011 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21791662
2.
Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN-191/RG7227) leads to robust reductions in viral RNA: a phase 1b multiple ascending dose study.
J Hepatol
; 54(6): 1130-6, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21145848
3.
Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227).
Antimicrob Agents Chemother
; 52(12): 4432-41, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18824605
4.
Immunomodulatory activities of IFN-gamma1b in combination with type I IFN: implications for the use of IFN-gamma1b in the treatment of chronic HCV infections.
J Interferon Cytokine Res
; 26(7): 473-83, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16800786